IRVINE, Calif.--(BUSINESS WIRE)--Cortex Pharmaceuticals, Inc. (OTCBB (CORX)) reported a net loss applicable to common stock of $1,599,000, or $0.02 per share for the quarter ended December 31, 2009 compared with a net loss of $3,130,000, or $0.07 per share for the corresponding prior year period. These reported losses included non-cash stock-based compensation charges for the quarters ended December 31, 2009 and 2008 of approximately $118,000 and $236,000, respectively.
